Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ambea ABCHIX:AMBEAS 83 EV-to-OCF is 11.81 as of Aug. 04, 2026, which is 1% above its 10-year median of 11.65. GuruFocus rates CHIX:AMBEAS with a GF Score™ of 83/100 and a GF Value™ of kr111.16 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 682 Healthcare Providers & Services companies, Ambea AB ranks worse than 60.26% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Ambea AB's Enterprise Value is kr24,749 Mil.
Ambea AB's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was kr2,096 Mil. Therefore, Ambea AB's EV-to-OCF for today is 11.81.
The historical rank and industry rank for Ambea AB's EV-to-OCF or its related term are showing as below:
CHIX:AMBEAs'
s EV-to-OCF Range Over the Past 10 Years
Min: 8.89 Med: 11.65 Max: 31.44
Current: 11.67
During the past 12 years, the highest EV-to-OCF of Ambea AB was 31.44. The lowest was 8.89. And the median was 11.65.
CHIX:AMBEAs's EV-to-OCF is ranked worse than 60.26% of 682
companies
in the Healthcare Providers & Services industry
Industry Median: 8.74
vs CHIX:AMBEAs: 11.67
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Ambea AB's share price for today is kr144.20.
Ambea AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr8.530.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Ambea AB EV-to-OCF Related Terms
Ambea AB EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Ambea AB's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:AMBEAS vs HCA, THC, DVA: EV-to-OCF Comparison
For the Medical Care Facilities subindustry, Ambea AB's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ambea AB EV-to-OCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ambea AB's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Ambea AB's EV-to-OCF falls into.
Ambea AB's current Enterprise Value is kr24,749 Mil.
Ambea AB's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr2,096 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ambea AB (CHIX:AMBEAS) has a EV-to-OCF of 11.81 as of Aug. 04, 2026. This is near median its historical median of 11.65. Over the past decade, Ambea AB's EV-to-OCF has ranged from 8.89 to 31.44. According to the industry distribution chart, Ambea AB ranks #411 out of 682 companies in the Healthcare Providers & Services industry, placing it in the top 60.3%.
Is Ambea AB's EV-to-OCF too high?
Ambea AB's current EV-to-OCF of 11.81 is near median its 10-year median of 11.65. Over the past 10 years, this metric has ranged from a low of 8.89 to a high of 31.44. The Healthcare Providers & Services industry median EV-to-OCF is 8.74. Ambea AB's value of 11.81 is 35.1% above this industry median. Based on the distribution chart, Ambea AB ranks #411 out of 682 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Ambea AB has a GF Score™ of 83/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ambea AB's EV-to-OCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Ambea AB ranks #411 out of 682 companies for EV-to-OCF. This places Ambea AB in the lower half of its industry. The industry median EV-to-OCF is 8.74. Ambea AB's value of 11.81 is 35.1% above this benchmark. Historically, Ambea AB's own EV-to-OCF has ranged from 8.89 to 31.44 over the past decade. While the company's 10-year median is 11.65 vs. the industry median of 8.74, Ambea AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Healthcare Providers & Services company?
The median EV-to-OCF among Healthcare Providers & Services companies is 8.74, based on 682 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ambea AB's current EV-to-OCF of 11.81 is 35.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median EV-to-OCF is 8.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ambea AB's current EV-to-OCF is 11.81, which is near median its own 10-year median of 11.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ambea AB stock overvalued right now?
Based on GuruFocus' analysis, Ambea AB (CHIX:AMBEAS) is currently considered Modestly Overvalued. The stock's GF Value™ is kr111.16, compared to a current price of kr144.20 — trading 29.7% above its estimated fair value. The current EV-to-OCF is 11.81, which is near median its 10-year median of 11.65 and 35.1% above the Healthcare Providers & Services industry median of 8.74. Ambea AB's overall GF Score™ is 83/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Ambea AB (CHIX:AMBEAS), the current EV-to-OCF is 11.81 as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ambea AB (CHIX:AMBEAS) Overvalued in 2026?
Based on GuruFocus' analysis, Ambea AB stock appears to be overvalued.
The current stock price of kr144.20 is trading 29.7% above its estimated GF Value™ of kr111.16.
GuruFocus considers Ambea AB to be Modestly Overvalued.
Key valuation signals for CHIX:AMBEAS:
EV-to-OCF: 11.81 (near median its 10-year median of 11.65)
GF Value™: kr111.16 vs. price of kr144.20 (29.7% above fair value)
Industry Position: 35.1% above the Healthcare Providers & Services median (#411 of 682)
No single metric tells the full story. See the CHIX:AMBEAS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ambea AB is a Swedish care-provider group focused on elderly care, disability care, psychosocial support, housing, staffing, and training across the Nordic region. The company's segment includes: i) Nytida: Comprises social care services for children, youth and adults, in Sweden, ii) Vardaga: Comprises nursing homes and home care in Sweden, iii) Stendi: Comprises social care for children, youth and adult in Norway, iv) Validia: Comprises social care for children, v) Altiden: Comprises social care for children, youth and adults as well as elderly care in Denmark, and vi) Klara: Comprises competence and staffing solutions for elderly and social care, and student health services in Sweden. The majority of the company's revenue is derived from the Vardaga segment.
83GF Score
Get the complete analysis for CHIX:AMBEAS
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:AMBEAS has been successfully added to your 
